You are here: Home: OPU 1 | 2006 : CME Information

Oncology Practice Update — A Continuing Education Audio Series

STATEMENT OF NEED/TARGET AUDIENCE

Breast cancer is one of the most rapidly evolving fields in oncology. Published results from a plethora of ongoing clinical trials lead to the continuous emergence of new therapeutic agents, changes in the indications for existing treatments and unique symptomatologies associated with those advances. In order to offer optimal patient care — including the option of clinical trial participation — the nurse practitioner, physician assistant and registered nurse specializing in oncology care must be well informed of these advances. To bridge the gap between research and patient care, Oncology Practice Update (OPU) will communicate the perspectives of leading oncology investigators and simultaneously balance those perspectives with those of practicing clinicians. By providing access to the latest research developments and expert perspectives as well as case-based discussions between researchers and practicing clinicians, OPU will assist nurse practitioners and physician assistants in the formulation of up-to-date clinical management strategies.

PURPOSE STATEMENT

To present the most current research developments in breast cancer and to provide the perspectives of medical oncologists, oncology nurses and physician assistants on the diagnosis and treatment of breast cancer.

LEARNING OBJECTIVES

• Describe the computerized risk models and genetic markers available to determine a patient’s quantitative risk of breast cancer relapse including how to use these to guide adjuvant therapy decisions.
• Describe the absolute risks, benefits and toxicities of various adjuvant systemic therapy approaches, including supportive care strategies available to manage these toxicities.
• Discuss selection and sequencing of endocrine therapy and chemotherapy for metastatic disease including the risks, benefits and toxicities of these therapies.
• Describe management strategies for primary prevention and treatment of treatment-related hematologic toxicities, including individual patients’ risks of developing these toxicities.
• Discuss how to incorporate the individual patient psychosocial situation, needs and values into discussions of systemic therapy options.

HOW TO USE THIS ACTIVITY

This activity contains both audio and print components. This monograph contains edited comments, clinical trial schemas, graphics and references that supplement the audio program. OncologyPracticeUpdate.com includes an easy-to-use interactive version of this monograph with links to relevant full-text articles, abstracts, trial information and other web resources indicated here in blue underlined text. There are no fees for participating and receiving credit for this activity. To receive credit during the period of April 2006 through April 2007, participants should read the learning objectives and faculty disclosures, listen to the CDs, review the monograph and complete the post-test and evaluation form located in the back of this monograph or on the website.

---

CNE INFORMATION CNA/ANCC This educational activity for 3.3 contact hours is provided by Postgraduate Institute for Medicine. Postgraduate Institute for Medicine is an approved provider of continuing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. California Board of Registered Nursing Postgraduate Institute for Medicine is approved by the California Board of Registered Nursing, Provider Number 13485, for 3.3 contact hours. AANP This program has been approved for 2.9 contact hours of continuing education (which includes 2.4 hours of pharmacology) by the American Academy of Nurse Practitioners. Program ID 0603102.

CME - PA INFORMATION CME–AAPA This program has been reviewed and is approved for a maximum of 2.75 hours of AAPA Category I (Preapproved) CME credit by the Physician Assistant Review Panel of the American Academy of Physician Assistants. Approval is valid for one year from the issue date of April 2006. Participants may submit the self- assessment at any time during that period. This program was planned in accordance with AAPA’s CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs. STATEMENT OF CREDIT A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed post-test with a score of 70% or better. Your statement of credit will be mailed to you within four to six weeks.

 

Table of Contents

Top of Page